Prognostic potential of MDM2 309T>G polymorphism in stage I lung adenocarcinoma.

被引：0
|
作者：
Shimizu, Kimihiro
Enokida, Yasuaki
Atsumi, Jun
Kakegawa, Seiichi
Takase, Yoshiaki
Nakazawa, Seshiru
Nagashima, Toshiteru
Ohtaki, Yoichi
Tanaka, Kazumi
Kaira, Kyoichi
Takeyoshi, Izumi
机构：
[1] Gunma Univ, Grad Sch Med, Div Thorac & Visceral Organ Surg, Maebashi, Gunma 371, Japan
[2] Gunma Univ, Grad Sch Med, Dept Thorac & Visceral Surg, Maebashi, Gunma 371, Japan
[3] Gunma Univ, Grad Sch Med, Dept Med & Mol Sci, Maebashi, Gunma 371, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.11055
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
11055
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Prognostic potential of the MDM2 309T>G polymorphism in stage I lung adenocarcinoma
    Enokida, Yasuaki
    Shimizu, Kimihiro
    Atsumi, Jun
    Kakegawa, Seiichi
    Takase, Yoshiaki
    Kaira, Kyoichi
    Yashima, Hideaki
    Araki, Takuya
    Nakazawa, Seshiru
    Ohtaki, Yoichi
    Nagashima, Toshiteru
    Alexander, Lezhava
    Usui, Kengo
    Ishikawa, Toshihisa
    Hayashizaki, Yoshihide
    Takeyoshi, Izumi
    CANCER MEDICINE, 2016, 5 (08): : 1791 - 1801
  • [2] MDM2 309 T/G polymorphism is associated with lung cancer risk among Asians
    Gui, Xian-Hua
    Qiu, Li-Xin
    Zhang, Hai-Feng
    Zhang, De-Ping
    Zhong, Wen-Zhao
    Li, Jin
    Xiao, Yong Long
    EUROPEAN JOURNAL OF CANCER, 2009, 45 (11) : 2023 - 2026
  • [3] MDM2 T309G POLYMORPHISM AND RISK OF COLORECTAL CANCER
    Aggarwal, N.
    Donald, N. D.
    Malik, S.
    Selvendran, S. S.
    McPhail, M.
    Monahan, K. J.
    GUT, 2017, 66 : A126 - A127
  • [4] MDM2 309T>G polymorphism in human sarcomas
    Biason, P.
    Masier, S.
    Serra, M.
    Scotlandi, K.
    Cecchin, E.
    Sartor, F.
    Biscontin, G.
    Toffoli, G.
    EJC SUPPLEMENTS, 2006, 4 (12): : 180 - 181
  • [5] Impact of MDM2 309T>G polymorphism on sarcomagenesis
    Liu, Hua-Wei
    Ni, Ming
    Li, Xiang
    Chen, Hui
    Zhang, Guo-Qiang
    Chai, Wei
    Xu, Meng
    Zhou, Yong-Gang
    Chen, Ji-Ying
    Wang, Yan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (08): : 12810 - 12817
  • [6] MDM2 T309G polymorphism is associated with bladder cancer
    Onat, Onur Emre
    Tez, Mesut
    Ozcelik, Tayfun
    Toruner, Gokce A.
    ANTICANCER RESEARCH, 2006, 26 (5A) : 3473 - 3475
  • [7] MDM2 T309G polymorphism is associated with bladder cancer
    Onat, O. E.
    Tez, M.
    Ozcelik, T.
    Toruner, G. A.
    FEBS JOURNAL, 2006, 273 : 225 - 226
  • [8] MDM2 309T>G POLYMORPHISM AND RISK OF LUNG CANCER IN A JAPANESE POPULATION
    Kakegawa, Seiichi
    Shimizu, Kimihiro
    Enokida, Yasuaki
    Kawashima, Osamu
    Kamiyoshihara, Mitsuhiro
    Sugano, Masayuki
    Ibe, Takashi
    Nagashima, Toshiteru
    Ohtaki, Yoichi
    Atsumi, Jun
    Obayashi, Kai
    Takeyoshi, Izumi
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1081 - S1081
  • [9] MDM2 309T>G polymorphism and risk of lung cancer in a Korean population
    Park, Sun Ha
    Choi, Jin Eun
    Kim, Eun Jin
    Jang, Jin Sung
    Han, Hyung Soo
    Lee, Won Kee
    Kang, Young Mo
    Park, Jae Yong
    LUNG CANCER, 2006, 54 (01) : 19 - 24
  • [10] The MDM2 promoter T309G polymorphism was associated with preeclampsia susceptibility
    Salimi, Saeedeh
    Mohammadpour-Gharehbagh, Abbas
    Rezaei, Mahnaz
    Sajadian, Mojtaba
    Teimoori, Batool
    Yazdi, Atefeh
    Mokhtari, Mojgan
    Yaghmaei, Minoo
    JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2017, 34 (07) : 951 - 956
12345